IDiyas

For the Inventor, By the Inventor

South Hamilton, MA, United States of America

David Fabrizio

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 6.5

ph-index = 8

Forward Citations = 238(Granted Patents)


Location History:

  • Swampscott, MA (US) (2013 - 2015)
  • South Hamilton, MA (US) (2016 - 2022)

Company Filing History:

goldMedal17 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents

Years Active: 2013-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 12194110 - PD-L1 binding polypeptides for imaging (2025-01-14),
2. 11344639 - PET imaging with PD-L1 binding polypeptides (2022-05-31),
3. 11203630 - Serum albumin-binding fibronectin type III domains (2021-12-21),
4. 11173219 - PD-L1 binding polypeptides for imaging (2021-11-16),
5. 11149077 - Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR (2021-10-19),
6. 10934572 - Serum albumin binding molecules (2021-03-02),
7. 10781247 - Targeted therapeutics based on engineered proteins that bind EGFR (2020-09-22),
8. 10442851 - Serum albumin-binding fibronectin type III domains (2019-10-15),
9. 10406251 - PD-L1 binding polypeptides for imaging (2019-09-10),
10. 10221438 - Serum albumin binding molecules (2019-03-05),
11. 10221232 - Methods of treating cancer by administering IGF-IR binding molecules (2019-03-05),
12. 9920108 - Targeted therapeutics based on engineered proteins that bind EGFR (2018-03-20),
13. 9540424 - Serum albumin binding molecules (2017-01-10),
14. 9234028 - Targeted therapeutics based on engineered proteins that bind EGFR (2016-01-12),
15. 8969289 - Serum albumin binding molecules (2015-03-03),

Title: The Innovations of Inventor David Fabrizio

Introduction:

David Fabrizio, an esteemed inventor based in South Hamilton, MA, has made significant contributions to the field of biotechnology with a total of 16 patents to his name.

Latest Patents:

Among his latest patents is the groundbreaking invention titled "PET Imaging with PD-L1 Binding Polypeptides," which introduces novelFn3 domains that specifically bind to PD-L1. Additionally, he has patented "Serum Albumin-Binding Fibronectin Type III Domains," showcasing polypeptides that bind to serum albumin with unique south pole loop substitutions. These innovations pave the way for advanced diagnostics and therapeutic applications.

Career Highlights:

David Fabrizio is associated with the renowned company Bristol-Myers Squibb Company. His tenure at this respected organization has been marked by a dedication to pioneering research and development in the biotech industry.

Collaborations:

Throughout his career, David Fabrizio has collaborated with talented individuals such as Ray Camphausen and Paul E Morin. These collaborations have played a vital role in bringing his innovative ideas to fruition and advancing the field of biotechnology.

Conclusion:

Inventor David Fabrizio's impressive portfolio of patents underscores his commitment to pushing the boundaries of biotechnological innovation. His contributions continue to drive progress in the field, shaping the future of diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…